HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Edmund Tse Selected Research
Edmund Tse Research Topics
Disease
8
Infections
12/2023 - 05/2015
4
Neoplasms (Cancer)
05/2024 - 01/2023
4
Fibrosis (Cirrhosis)
11/2021 - 05/2016
3
Chronic Hepatitis C
12/2023 - 05/2015
2
Hepatitis C
01/2023 - 01/2017
2
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2023
2
Autoimmune Hepatitis
01/2019 - 01/2018
2
Liver Diseases (Liver Disease)
01/2018 - 05/2016
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023
1
Stomach Neoplasms (Stomach Cancer)
01/2023
1
Cardiotoxicity
11/2022
1
Immunoglobulin G4-Related Disease
12/2021
1
Sclerosing Cholangitis
12/2021
1
Portal Hypertension
11/2021
1
Dysentery
10/2020
1
Chronic Hepatitis B
01/2020
1
Hepatocellular Carcinoma (Hepatoma)
01/2019
1
Hepatitis
01/2018
1
Non-alcoholic Fatty Liver Disease
05/2015
1
Acute Kidney Injury (Acute Renal Failure)
07/2011
Drug/Important Bio-Agent (IBA)
7
Antiviral Agents (Antivirals)
IBA
12/2023 - 05/2015
4
Ribavirin (Virazole)
FDA Link
Generic
01/2017 - 05/2015
3
Interferons
IBA
11/2023 - 05/2015
2
RNA (Ribonucleic Acid)
IBA
11/2023 - 01/2023
2
DNA (Deoxyribonucleic Acid)
IBA
11/2023 - 01/2023
2
Hepatitis B Core Antigens
IBA
11/2023 - 01/2023
2
Hepatitis B e Antigens
IBA
11/2023 - 01/2023
2
Hepatitis B Surface Antigens (HBsAg)
FDA Link
11/2023 - 01/2023
2
Immunologic Factors (Immunomodulators)
IBA
11/2023 - 01/2023
2
Immunoglobulin G (IgG)
IBA
12/2021 - 01/2019
2
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2019 - 01/2018
2
daclatasvir
IBA
05/2016 - 05/2015
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2024
1
Cytokines
IBA
05/2024
1
Sphingolipids
IBA
05/2024
1
amsonic acid (DAS)
IBA
01/2024
1
Circular DNA
IBA
11/2023
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
Immune Checkpoint Inhibitors
IBA
01/2023
1
ezrin
IBA
01/2023
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2023
1
Anthracyclines
IBA
11/2022
1
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2022
1
Polysaccharides (Glycans)
IBA
10/2020
1
O Antigens (O Antigen)
IBA
10/2020
1
Lipopolysaccharides
IBA
10/2020
1
Blood Group Antigens (Blood Groups)
IBA
10/2020
1
Immunoglobulins (Immunoglobulin)
IBA
01/2019
1
Cytochrome P-450 CYP2B1 (PROD)
IBA
01/2017
1
paritaprevir
IBA
01/2017
1
ombitasvir
IBA
01/2017
1
dasabuvir
IBA
01/2017
1
Albumins
IBA
01/2017
1
Creatinine
IBA
01/2017
1
Cytidine Triphosphate (CTP)
IBA
01/2017
1
Ritonavir (Norvir)
FDA Link
01/2017
1
Nucleotides
IBA
05/2016
1
Sofosbuvir
IBA
05/2016
1
Proteins (Proteins, Gene)
FDA Link
05/2016
1
asunaprevir
IBA
05/2015
1
8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamide
IBA
05/2015
1
Vancomycin
FDA Link
Generic
07/2011
Therapy/Procedure
8
Therapeutics
12/2023 - 07/2011
2
Immunotherapy
05/2024 - 01/2023
2
Radiotherapy
01/2023 - 01/2019
1
Continuity of Patient Care
12/2023
1
Chemoradiotherapy
01/2023
1
Drug Therapy (Chemotherapy)
01/2023
1
Liver Transplantation
11/2021
1
Salvage Therapy
01/2019